State of New Jersey Common Pension Fund D’s Allogene Therapeutics ALLO Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-83,099	Closed	-$2.17M	–	1731
2021 Q2	$2.17M	Buy	83,099 +11,063	+15%	+$315K	0.01%	1697
2021 Q1	$2.54M	Buy	72,036 +13,182	+22%	+$445K	0.01%	1289
2020 Q4	$1.49M	Sell	58,854 -6,150	-9%	-$200K	0.01%	1544
2020 Q3	$2.45M	Buy	65,004 +21,540	+50%	+$812K	0.01%	1035
2020 Q2	$1.86M	Buy	+43,464	New	+$1.57M	0.01%	1494

Other funds holding ALLO

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State of New Jersey Common Pension Fund D's ALLO Position: Q3 2021 in Review

State of New Jersey Common Pension Fund D sold out of Allogene Therapeutics (ALLO) in Q3 2021, closing a stake of 83,099 shares — an estimated $2.17M sold.

State of New Jersey Common Pension Fund D first reported a position in ALLO in Q2 2020 and held it in 5 quarters. The position peaked at $2.54M in Q1 2021. 169 funds tracked by Wall St. Rank hold ALLO as of Q3 2021.

State of New Jersey Common Pension Fund D reported no remaining Allogene Therapeutics position as of Q3 2021 after selling out during the quarter.
State of New Jersey Common Pension Fund D sold 83,099 Allogene Therapeutics shares in Q3 2021, an estimated $2.17M.
State of New Jersey Common Pension Fund D first reported a position in Allogene Therapeutics in Q2 2020 and held it in 5 quarters.
State of New Jersey Common Pension Fund D's Allogene Therapeutics position peaked at $2.54M in Q1 2021.
169 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2021.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q3 2021, filed 27 Oct 2021.